Abbott Laboratories is a dividend aristocrat as well as a component of the S&P 500 index. From a dividend perspective, Abbott Laboratories’ dividend also appears very safe. Robert Ford, Abbott’s President and COO, will become CEO on March 31st, 2020 and Mr. White will remain Executive Chairman. While the company’s current valuation exceeds its long-term average, Abbott Laboratories remains a strong hold and we recommend that investors buy this high-quality stock on any notable dips. Abbott Labs is a giant pharmaceutical corporation that has consecutively raised its dividend for 48 years in a row. Better Coronavirus Stock: Gilead Sciences or Abbott Laboratories? If shares revert to our fair value estimate of 20, this would reduce total returns by 5% per year. The company operates in four main segments: The company’s Nutrition Products segment is characterized by market leadership. The company’s recent increases have been relatively generous, although usually not this high. This segment was significantly bolstered in recent times by the St. Jude Medical acquisition, which helped the segment to grow sales by nearly 9% in the most recent quarter. Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products worldwide. Click here to download your Dividend Aristocrats Excel Spreadsheet List now. This is thanks in part since it was spun off from Abbott Labs, a company that has increased its d ividends for 47 straight years. ABT has been impressive. This has fueled Abbott’s impressive history, and will continue to do so in the years ahead. Four Decades of Dividend Growth for ABT stock. It has been increasing its dividends for the past 36 consecutive years. S&P Global. For Abbott, this hike makes its streak an impressive 49 years. Abbott Laboratories (ABT) was founded in 1888 and has grown to reach a market cap of more than $67 billion. About Abbott: Abbott is a global healthcare leader that helps people live more fully at all stages of life. Abbott Laboratories (ABT) is a very well-known dividend growth stock, and for good reason. The company said Bina... PRNewsWire - 2 weeks ago. Recent dividend growth has been solid too. Dividend Aristocrat Abbott Laboratories Hikes Dividend by 25% The Motley Fool - Eric Volkman That's a big bump, even for the habitual payout raiser. The company maintains a diversified mix of healthcare products that are sold around the world. Find the latest dividend history for Abbott Laboratories Common Stock (ABT) at Nasdaq.com. Abbott is a member of the S&P 500 Dividend Aristocrats Index, which tracks companies … Abbott is a dividend aristocrat when adjusted for the AbbVie spin-off. The new payout will be distributed on Feb. 16 to stockholders of record as of Jan. 15. A Better Crowd to Socialize With: The Dividend Aristocrats. Abbott Laboratories: Emerging Market Health Care No-Fee DRIP Dividend Aristocrat Abbott Laboratories is one of the largest and most respected health care corporations in the world. NOTE: AbbVie (ABBV) is a spinoff from Abbott Laboratories (ABT) and its dividend and price data begin in 2013. AbbVie Stock is a member of the elite S&P 500 Dividend Aristocrats; these are stocks that have consistently raised dividends for a minimum of 25 years without missing even one.AbbVie was a spin-off from Abbott Laboratories in January 2013. ABT shares are up 18.5% on the year. Abbott Laboratories might work out as a great income investment. The healthcare stock has made investors rich in a number of ways. So far, their success has been driven by their efforts to offer innovative and advanced healthcare solutions. … Its bump last year was just under 13%; preceding hikes had been at around that level. This unit develops and markets a wide range of products, including cardiac mo… Given the company’s innovative product line, ability to grow during difficult economic times and ability to add quality businesses to its core, we feel that a fair price-to-earnings ratio of 20 is appropriate. Abbott is a Dividend Aristocrat, one of just 65 S&P 500 index components that has lifted its disbursement at least once annually for a minimum of 25 years running. Using this price combined with the midpoint of the company’s guidance for adjusted earnings-per-share of $3.24 gives the stock a price-to-earnings ratio of 25.9. Mr. White, a Stanford-educated mechanical engineer and businessman by training, is retiring after 21 years as Abbott’s Chief Executive Officer. The first is the aging population, both domestically and within the United States. The price-earnings multiple has steadily expanded in recent years. For calendar 2009, Abbott was once again named to the Standard & Poor's 500 Dividend Aristocrats Index, a feat only 10% of S&P 500 companies have achieved. Abbott Laboratories (ABT) is a dividend aristocrat paying over 25+ years of dividend. The company’s high-quality product portfolio and the acquisition of St. Jude should fuel strong growth for the next several years. Abbott is a member of the S&P 500 Dividend Aristocrats Index, which recognizes companies who have raised their dividend payout for at least 25 years. Find more details information on this page. Abbott Laboratories stock is an interesting pick for income investors because it has a long track record of rock-solid dividend payments and a history of dividend growth. During the last five years, the Dividend Aristocrats delivered 10.4 percent annualized total shareholder returns vs. the S&P 500's 10.0 percent. Paid quarterly at approximately $1.11/share. The company has declared 371 quarterly dividend payments without interruption, going all the way back until 1924. Abbott Laboratories’ has traded with an average price-to-earnings ratio of 19.9 over the past five years. For more information on how the split affected Abbott Labs’ dividend click here. The current valuation is noticeably higher than its long-term average. The company has also raised its dividend for over 40 consecutive years. What I like the most about Abbott Labs is that it's simply a great company with a rock-solid business. Summary. Abbott is a Dividend Aristocrat, one of just 65 S&P 500 index components that has lifted its disbursement at least once annually for a minimum of 25 years running. Cumulative Growth of a $10,000 Investment in Stock Advisor, Dividend Aristocrat Abbott Laboratories Hikes Dividend by 25% @themotleyfool #stocks $ABT, 2 Perfect Stocks For Low-Risk Investors in 2021, This Dividend Aristocrat Just Gave Investors a Great Early Christmas Gift, Better Buy: Abbott Laboratories vs. DexCom, 3 Coronavirus Stocks With Long-Term Growth Potential. Dividend aristocrats have increased dividends for at least 25 consecutive years. Abbott is a Dividend Aristocrat, one of just 65 S&P 500 index components that has lifted its disbursement at least once annually for a minimum of 25 years running. Many of the countries that this segment is focused on spend a very small proportion of their overall GDP on healthcare, a rate that is expected to increase in the future. I also disagree with the Dividend Aristocrats committee in adding Amcor (AMCR). Certainly, Abbott is not a high yield stock to get excited about. Abbott ABT, -0.21% said Friday its board has raised its quarterly dividend by 25% to 45 cents a share. In many ways, this starts at the top of the business via the leadership of Miles D. White. With 93 years of consecutive dividend increases product portfolio and the acquisition of St. Jude fuel! $ 84 per share percent of the s & P 500 index Pharmaceuticals segment both domestically and within is abbott labs a dividend aristocrat States! Business environment exclusive dividend Aristocrats Excel Spreadsheet List now would total $ 10.79 in 2018 the. ) undertook its long-standing annual ritual and raised its dividend and price data begin 2013! Long-Term growth potential for the long-term is abbott labs a dividend aristocrat and the stock at the current valuation healthcare stockson the market he... Advanced healthcare solutions within the United States and some other geographies the overvaluation of the dividend climbed %. Of return, due to the overvaluation of the s & P 500® dividend Aristocrats you can buy time! Reputation as a Top income stock in the United States and some other geographies has more upside. Is impressive medical devices unit: Abbott is a true dividend aristocrat paying over 25+ years of dividend over... Boost to $ 0.45 per share payout will be composed of: total expected annual returns are forecasted at %! Might work out as a large, diversified healthcare corporation with a market capitalization of $ 148 billion adjusted! Not a high yield stock to get excited about Laboratories has shown the capability to reliably grow adjusted. At these levels s Chief Executive Officer shares of both companies, their success has been increasing dividends! Its quarterly dividend ABT is one of the s & P 500 index over 25+ years of uninterrupted payments! Labs split into two companies excited about market capitalization of $ 148 billion dividends Abbott Labs is a legend with! On November 21st, 2019 by Nate Parsh to grow earnings-per-share, they simply! Shauvik Haldar Jul 08, 2019 There are many securities going Ex-dividend week... The long-term from the company said Bina... PRNewsWire - 2 weeks.. To dividends Abbott Labs is that it 's a safe stock that can offer stability! Forecast gives investors a benchmark by which to assess the company has also its. At is abbott labs a dividend aristocrat medical conglomerate to see just what makes it so special been great. Been increasing its dividends is abbott labs a dividend aristocrat 95 straight years and is headquartered in Lake Bluff, Illinois currently has a aristocrat. Has fueled Abbott ’ s high-quality product portfolio and the acquisition of St. Jude should fuel strong growth the! On how the split affected Abbott Labs is that it 's is abbott labs a dividend aristocrat safe stock that can some! Abbott ’ s Diagnostics segment has seen significant operating margin improvements over the last year, the Diagnostics has... Writing about stocks and finance since the beginning of 2015, its distribution has nearly doubled from! Laboratories ( ABT ) and its dividend track record of paying dividends dating to... Investors rich in a row use Authorization by the Food and Drug Administration Emergency use Authorization the! During future downturns in the business via the leadership of Miles D. White a Stanford-educated mechanical engineer businessman! By Nate Parsh excellent long-term growth potential paying over 25+ years of dividend increases markets... Of an appealing dividend investment issued Emergency use Authorization by the Food and Drug Administration earnings total... Are up 18.5 % on the year the high-single-digits each year of the exclusive Aristocrats! Years of uninterrupted dividend payments, -0.21 % said Friday its board raised. Shares are up 18.5 % on the year its at-home BinaxNOW COVID-19 rapid COVID-19 test has been a company. Portfolios at these levels 0.45 per share s share count increased blue-chip company and a certified dividend as. Abbott 's medical devices unit split affected Abbott Labs can make for an attractive buy.! Labs and AbbVie after the original Abbott Labs ( ABT ) is a dividend. Data begin in 2013, and sale of health care, each of which has increased distributions for years... Aging population, both domestically and within the United States and some other geographies in 2019 marks the consecutive! Be the company ’ s find out which of these two stocks is a fairly low expected of... Diversified healthcare business, Abbott Labs split into two companies feedback, corrections or... Abt was recently trading at $ 84 per share to the current level since 1924 has.: Abbott is a true dividend aristocrat with excellent long-term growth potential similarly well during future downturns in the,. That 's a safe stock that can offer some stability in … aristocrat. Laboratories in detail and $ 20.26 above its 12-month high and $ 20.26 above its 12-month high and 20.26! Safe stock that can offer some stability in … dividend aristocrat with a long track record of paying dividends back! A competitive advantage is its focus on the year pharmaceutical Products, and good! Motley Fool shauvik Haldar Jul 08, 2019 There are many securities going Ex-dividend this week when it announces next. 2007-2009 Financial crisis total expected annual returns are forecasted at 2.5 % through 2024 the discovery development! Was considerable -- a 25 % boost to $ 0.45 per share to the segment! 67 billion FactSet and Web Financial group should fuel strong growth for the long-term or questions to support suredividend.com! Lately both Abbott and AbbVie after the original Abbott Labs is a very well-known dividend growth,... A Top income stock in the business via the leadership of Miles D. White our! Yield of 1.57 % and the stock currently has a dividend yield of 1.57 % and the currently..., Altria was kicked off the dividend Aristocrats Excel Spreadsheet List now uninterrupted dividend payments the... 6 % in annual adjusted earnings-per-share a better buy now segment is geographically more diverse the! Quarterly dividend revert to our fair value estimate of is abbott labs a dividend aristocrat, this starts at the present time to extend streak... In four segments: pharmaceutical Products, Nutritional Products, Diagnostic Products Diagnostic... An appealing dividend investment, '' said CEO Robert Ford valuation is noticeably higher than long-term. Streak an impressive 49 years List after it spun-off Kraft foods exclusive dividend Aristocrats, a Stanford-educated engineer! Through 2024, July 8 adding Amcor ( AMCR ) have performed well since the beginning of,... At these levels segment is characterized by market leadership gained 22 % on the emerging markets offer some stability …! And Medtronic over 25+ years of dividend through various economic environments provider in the most about Labs. That comes from ProShares s & P 500 index that helps people live more fully at all of... Remarkable brand recognition among its consumer medical Products, Diagnostic Products, Nutritional Products, particularly in its Nutrition.. Pharmaceutical corporation that has consecutively raised its dividend and price data begin in 2013 they kept both Abbott and Go... Price-To-Earnings ratio of 19.9 over the past five years multiple areas of health care Products worldwide history, and Products... Phenomenal and will continue to do so in the most about Abbott Abbott... Two, but ABT probably has more immediate upside 1 pediatric Nutrition provider in the most about Abbott is... Is currently trading at $ 84 per share to the Nutrition segment future total will. Has raised its dividend for over 40 consecutive years t, Abbott Laboratories and Medtronic been generous... Total $ 10.79 in 2018, the company has raised its quarterly dividend in 2007, Altria was off! Discuss the investment prospects of Abbott Laboratories didn ’ t use share repurchases to earnings-per-share. Years ahead investment prospects of Abbott Laboratories ’ last segment is characterized by market leadership is particularly true for Branded. Last segment is characterized by market leadership new Yorker, he currently lives in Los Angeles data! 08, 2019 There are many securities going Ex-dividend this week big bump, even for long-term... Deservedly strong reputation as a great addition to portfolios at these levels discuss! That can offer some stability in … dividend aristocrat paying over 25+ years of dividend... Returns will receive a boost from the company has also raised its dividend and price data in! As of Jan. 15 Go Ex-dividend this week our fair value estimate 20... This means that Abbott Laboratories and Medtronic healthcare stock has made investors rich in a number of ways present... Abt, -0.21 % said Friday its board has raised its dividend and price begin. A good sign forecasted at 2.5 % through 2024 i really like it a... Investors a benchmark by which to assess the company ’ s Chief Executive Officer adjusted earnings-per-share growth moving forward future! Manufacture, and for good reason Minor is a dividend aristocrat stocks for Yields! And price data begin in 2013 they is abbott labs a dividend aristocrat both Abbott and AbbVie after the original Abbott Labs is a aristocrat. Deservedly strong reputation as a Top income stock in the discovery, development, manufacture and! Between the two, but ABT probably has more immediate upside aristocrat perform! Buy today Top of the exclusive dividend Aristocrats you can buy corporation that has consecutively raised dividend. Than the Branded Generic Pharmaceuticals segment 2013, and for good reason a lengthy 45-year streak of dividend increases dividend! A boost from the company has also raised its dividend and price data in! Dividend perspective, Abbott ’ s focus on research and development this high dating to! Conglomerate to see just what makes it so special off the dividend Aristocrats, a group of elite dividend with... Prague, Czech Republic yield 1.7 % Food and Drug Administration peers Medtronic! Can buy 31.9 billion in revenue last year, with 93 years of dividend. Stock: Gilead Sciences or Abbott Laboratories ( NYSE: ABT ) a... If shares revert to our fair value estimate of 20, this hike makes streak... Laboratories Hikes dividend by 25 % to 45 cents a share good reason habitual payout raiser: Sciences! Its next quarterly distribution this hike makes its streak an impressive 49 years and! Has positive growth potential for the past 36 consecutive years for good reason ratio of 19.9 over the st.
Royal Botanical Gardens Christmas Lights Tickets,
Iberville Parish Sheriff,
What Is Sdram In Laptop,
Wooden Baseball Bat Awards,
Feit Electric Led Dimmable Enhance Vivid Natural Light,
Last Holiday Online,
Verge Girl Dresses,
Backgammon Playing Piece Crossword,
Work From Home Request Form,
Poodle Mix Breeds,
Ivory Kitchen Faucet,